ACTRN12613000594729招募中未知
Study comparing differences in fibroblast growth factor 23 and other markers of bone turnover in men with various iron store states of iron overload, iron deficiency and normal iron stores.
Associate Professor Emily Hibbert0 个研究点目标入组 140 人开始时间: 2013年5月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 35 Years 至 o limit（—）
- 性别
- Male
入选标准
- •The study population will comprise males of age 35 years or greater who meet one of the following criteria:
- •1.iron overload due to haemochromatosis with ferritin > 300microg/l, the upper limit of the reference range or
- •2.normal iron studies
- •3.iron deficiency with ferritin < 30 microg/l ie. below the lower limit of the reference range
排除标准
- •1.Intercurrent proven evidence of cancer – as this will affect ferritin levels and interpretation and may alter FGF 23
- •2.Active infection- will affect ferritin levels and interpretation and may alter FGF 23
- •3.Chronic kidney disease with eGFR< 50 - as eGFR drops, FGF23 levels rise rapidly
- •4.Current glucocorticoid use,
- •5.Hypercalcaemia
- •6.Vitamin D deficiency with 25OH vitamin D level < 25 nmol/l
研究者
相似试验
已完成
不适用
The efficacy of fibroblast growth factor for the treatment of chronic vocal fold scarringSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0001855Soon Chun Hyang University Hospital Bucheon17
进行中（未招募）
Unknown
Efficacy of nuclear medicine imaging to detect fibroblast activation protein in pancreatic and biliary tract cancer.NeoplasmsKCT0009207Seoul National University Hospital30
已完成
3 期
A Non-Inferiority Study Evaluating Fibroblast Growth Factor-2 (KCB-1D) to Enamel Matrix Derivative (Emdogain(R)Gel) for Periodontal Tissue Regeneration.patients with periodontitis who require surgical intervention (flap surgery)JPRN-UMIN000008231KAKEN PHARMACEUTICAL CO., LTD.240
进行中（未招募）
不适用
Clinical study to compare recombinant human growth hormone Cristalia(r-hGH Cristalia) versus Genotropin® in prepubertal children withgrowth deficiency due to deficiency of growth hormone.Growth deficiency due to growth hormone deficiencyMedDRA version: 18.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disordersEUCTR2016-000446-56-Outside-EU/EEACristália Produtos Químicos Farmacêuticos Ltda.94
尚未招募
3 期
Clinical study to compare recombinant human growth hormone Cristália (r-hGH Cristália) versus Genotropin® pre puberty in children with failure to thrive due to deficiency of growth hormone.Growth deficiency due to growth hormone deficiencyM89.2RBR-85bbp4ICF - Instituto de Ciências Farmaceuticas de Estudos e Pesquisas LTDA